Expediting regulatory submission: Supporting biotech milestones in infant gene therapy trials

Unlocking Biotech Potential: Delivering Expedited Data Management

Serving as an Extended Safety Partner for an Emerging Biotech’s Vaccine Study

Novel Remote Visit Approach in Japan: Advancing Patient-Centric ALS Clinical Trials

Empowering Biotech Innovations: End-to-End Solutions for Immunotherapy Trials

Onsite manufacture can accelerate your Phase I small molecule program

Diane Ostang

Diane Ostang, Delivery Director, has a background in Biomedical Engineering and brings over 22 years of industry experience across various therapeutic areas, with over 18 years as part of Fortrea team.

Richard Gambie

Richard has more than 27 years of industry experience from Pre-Clinical work in the Pharmaceutical sector to Data Management, CRA & Project Management, in multiple therapeutic areas, focusing on Ophthalmol

Five breakthrough moments from AAIC 2025 that are reshaping Alzheimer's research